Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)

Sinil Pharmaceutical Revenue

Sinil Pharmaceutical had revenue of 20.87B KRW in the quarter ending March 31, 2026, with 8.41% growth. This brings the company's revenue in the last twelve months to 82.18B, down -4.35% year-over-year. In the year 2025, Sinil Pharmaceutical had annual revenue of 80.56B, down -9.92%.

• Revenue (ttm): 82.18B
• Revenue Growth: -4.35%
• P/S Ratio: 0.75
• Revenue / Employee: 286.35M
• Employees: 287
• Market Cap: 61.66B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	80.56B	-8.88B	-9.92%
Dec 31, 2024	89.44B	305.25M	0.34%
Dec 31, 2023	89.14B	9.13B	11.41%
Dec 31, 2022	80.01B	18.25B	29.56%
Dec 31, 2021	61.75B	316.13M	0.51%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error